Skip to main content
. 2021 Aug 19;8:718184. doi: 10.3389/fsurg.2021.718184

Figure 4.

Figure 4

Survival curves 5 years after surgery according to (A) MYCN amplification (MYCN+), (B) International Neuroblastoma Staging System (INSS) classification, and (C) sarcopenic status.